PH12022550133A1 - Immunogenic composition comprising multivalent streptococcus pneumoniae polysaccharide-protein conjugates and pharmaceutical use thereof - Google Patents
Immunogenic composition comprising multivalent streptococcus pneumoniae polysaccharide-protein conjugates and pharmaceutical use thereofInfo
- Publication number
- PH12022550133A1 PH12022550133A1 PH1/2022/550133A PH12022550133A PH12022550133A1 PH 12022550133 A1 PH12022550133 A1 PH 12022550133A1 PH 12022550133 A PH12022550133 A PH 12022550133A PH 12022550133 A1 PH12022550133 A1 PH 12022550133A1
- Authority
- PH
- Philippines
- Prior art keywords
- streptococcus pneumoniae
- immunogenic composition
- protein conjugates
- multivalent
- pharmaceutical use
- Prior art date
Links
- 241000193998 Streptococcus pneumoniae Species 0.000 title abstract 4
- 229940031000 streptococcus pneumoniae Drugs 0.000 title abstract 4
- 230000002163 immunogen Effects 0.000 title abstract 3
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to an immunogenic composition comprising multivalent Streptococcus pneumoniae polysaccharide-protein conjugates. The respective conjugates comprise capsular polysaccharides of different Streptococcus pneumoniae serotypes conjugated to carrier proteins, and thus can induce immune responses to a wider variety of serotypes compared with existing Prevenar 13. The multivalent immunogenic composition according to the present invention can be advantageously used in preventing diseases caused by Streptococcus pneumoniae in infants, children, and adults.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20190087004 | 2019-07-18 | ||
| PCT/KR2020/009474 WO2021010798A1 (en) | 2019-07-18 | 2020-07-17 | Immunogenic composition comprising multivalent streptococcus pneumoniae polysaccharide-protein conjugates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12022550133A1 true PH12022550133A1 (en) | 2022-11-14 |
Family
ID=74211166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2022/550133A PH12022550133A1 (en) | 2019-07-18 | 2020-07-17 | Immunogenic composition comprising multivalent streptococcus pneumoniae polysaccharide-protein conjugates and pharmaceutical use thereof |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JP7441301B2 (en) |
| KR (1) | KR20210010412A (en) |
| CN (1) | CN114364397B (en) |
| AU (1) | AU2020315673B2 (en) |
| MY (1) | MY207971A (en) |
| PH (1) | PH12022550133A1 (en) |
| TW (1) | TWI864052B (en) |
| WO (1) | WO2021010798A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019050814A1 (en) * | 2017-09-07 | 2019-03-14 | Merck Sharp & Dohme Corp. | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| US11116828B2 (en) | 2017-12-06 | 2021-09-14 | Merck Sharp & Dohme Corp. | Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| GEP20247633B (en) | 2018-12-19 | 2024-06-25 | Merck Sharp & Dohme Llc | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| KR20220102871A (en) * | 2021-01-14 | 2022-07-21 | (주)셀트리온 | The immunogenic composition comprising multivalent pneumococcal polysaccharide-protein conjugate |
| GB2614916A (en) * | 2022-01-25 | 2023-07-26 | Optivalent Ltd | Intradermal vaccine complement |
| CN116942804A (en) * | 2022-04-19 | 2023-10-27 | 上海瑞宙生物科技有限公司 | Component of multivalent pneumococcal polysaccharide conjugate vaccine and application thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1973564T (en) * | 2005-12-22 | 2017-01-24 | Glaxosmithkline Biologicals Sa | Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| TW201136603A (en) * | 2010-02-09 | 2011-11-01 | Merck Sharp & Amp Dohme Corp | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| HRP20211288T1 (en) | 2014-01-21 | 2021-11-26 | Pfizer Inc. | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof |
| CN104069504B (en) * | 2014-05-11 | 2019-09-24 | 江苏康泰生物医学技术有限公司 | A method of enhancing polysaccharide protein conjugate immunogenicity |
| AU2017336806B2 (en) * | 2016-09-30 | 2024-06-27 | Biological E Limited | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates |
| ES3024474T3 (en) * | 2016-12-30 | 2025-06-04 | Vaxcyte Inc | Polypeptide-antigen conjugates with non-natural amino acids |
| KR102101879B1 (en) * | 2017-03-15 | 2020-05-29 | 주식회사 엘지화학 | Multivalent vaccine composition against streptococcus |
| CN108079286B (en) | 2018-01-19 | 2020-07-31 | 云南沃森生物技术股份有限公司 | 13-valent pneumococcal polysaccharide-protein conjugate composition and preparation method and application thereof |
-
2020
- 2020-07-17 PH PH1/2022/550133A patent/PH12022550133A1/en unknown
- 2020-07-17 CN CN202080051215.XA patent/CN114364397B/en active Active
- 2020-07-17 WO PCT/KR2020/009474 patent/WO2021010798A1/en not_active Ceased
- 2020-07-17 KR KR1020200089019A patent/KR20210010412A/en not_active Withdrawn
- 2020-07-17 JP JP2022503589A patent/JP7441301B2/en active Active
- 2020-07-17 AU AU2020315673A patent/AU2020315673B2/en active Active
- 2020-07-17 TW TW109124333A patent/TWI864052B/en active
- 2020-07-17 MY MYPI2022000293A patent/MY207971A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI864052B (en) | 2024-12-01 |
| MY207971A (en) | 2025-03-31 |
| TW202116352A (en) | 2021-05-01 |
| JP7441301B2 (en) | 2024-02-29 |
| AU2020315673A1 (en) | 2022-02-10 |
| WO2021010798A1 (en) | 2021-01-21 |
| KR20210010412A (en) | 2021-01-27 |
| JP2022540718A (en) | 2022-09-16 |
| CN114364397B (en) | 2024-03-29 |
| CN114364397A (en) | 2022-04-15 |
| AU2020315673B2 (en) | 2025-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12022550133A1 (en) | Immunogenic composition comprising multivalent streptococcus pneumoniae polysaccharide-protein conjugates and pharmaceutical use thereof | |
| MX2023009362A (en) | Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity. | |
| PH12014502843A1 (en) | Polyvalent pneumococcal polysaccharide-protein conjugate composition | |
| GEP20227420B (en) | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof | |
| BR112020004509A8 (en) | POLYSACCHARIDE-CARRIER PROTEIN CONJUGATE, IMMUNOGENIC COMPOSITION INCLUDING THE SAME AND USE OF SAID CONJUGATE | |
| PH12019500240A1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| PE20240927A1 (en) | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS THAT COMPRISE THEM AND THEIR USES | |
| BR112020004471A8 (en) | PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES | |
| MX2020002556A (en) | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates. | |
| BR112020004396A8 (en) | PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES | |
| TN2012000377A1 (en) | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition | |
| AR127517A2 (en) | COMPOSITION OF THE PNEUMOCOCCAL MULTIVALENT PROTEIN-POLYSACCHARIDE CONJUGATE | |
| PH12015501270A1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| PH12015501269A1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| SA519401028B1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| NO20082718L (en) | Vaccine | |
| NZ755770A (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| ZA202103560B (en) | Multivalent pneumococcal polysaccharide-protein conjugate vaccine | |
| AR114355A1 (en) | COMPOSITION OF THE PNEUMOCOCCAL MULTIVALENT PROTEIN-POLYSACCHARIDE CONJUGATE | |
| AR114442A1 (en) | COMPOSITION OF THE PNEUMOCOCCAL MULTIVALENT PROTEIN-POLYSACCHARIDE CONJUGATE | |
| EA202091440A1 (en) | POLIVALENT ANTI-Pneumococcal POLYSACCHARIDE-PROTEIN CONJUGATED COMPOSITION | |
| AR109377A1 (en) | MULTIVALLY CONJUGATED PNEUMOCOTIC COMPOSITION OF POLYACACRIDE AND PROTEIN | |
| EA201990131A1 (en) | POLYVALENT Pneumococcal Polysaccharide-Protein Conjugate Composition | |
| TH171459A (en) | Multivalent pneumococcal polysaccharide-protein conjugate |